Philippines at a glance
- Population
- 116.8 million 2025
- Life expectancy at birth
- 69.9 years, 2024
- People aged 65 and over
- 5.7 % of people, 2025
- Health spending per person
- 194 US$ per person, 2023
- Doctors
- 0.79 per 1,000 people, 2021
Updated
Reviewed by Vidhi Upadhyay
Philippines Cancer Genomic Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Sample, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$69.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $31.9 Mn | — | — |
| 2025 (base) | $35.9 Mn | +$4.1 Mn | — |
| 2026 (forecast) | $40.5 Mn | +$4.6 Mn | +12.7% |
| 2027 (forecast) | $45.7 Mn | +$5.1 Mn | +27% |
| 2028 (forecast) | $51.5 Mn | +$5.8 Mn | +43.1% |
| 2029 (forecast) | $58.0 Mn | +$6.5 Mn | +61.3% |
| 2030 (forecast) | $65.4 Mn | +$7.4 Mn | +81.8% |
| 2031 (forecast) | $73.7 Mn | +$8.3 Mn | +104.9% |
| 2032 (forecast) | $83.0 Mn | +$9.4 Mn | +130.9% |
| 2033 (forecast) | $93.5 Mn | +$10.5 Mn | +160.3% |
| 2034 (forecast) | $105.4 Mn | +$11.9 Mn | +193.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $35.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $105.4 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 12.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Test, sample and end user (see all) |
| Key players | Roche, Myriad Genetics, Inc., Illumina, Inc., Guardant Health, Inc., Caris Life Sciences and 1 more (see all) |
| Regulator in the Philippines | FDA PhilippinesSource: Food and Drug Administration Philippines. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Cancer genomic tests read the DNA of tumours or blood to find mutations that guide treatment or show inherited cancer risk.
Key segments of the cancer Genomic Testing market include test (Comprehensive Genomic Profiling, Hereditary Cancer Panels and Single-Gene Tests) and sample (Tissue, Blood and Saliva).
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the cancer Genomic Testing market. Faster approvals and new combinations are improving survival.
Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the cancer Genomic Testing market.
High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the cancer Genomic Testing market, especially in low- and middle-income countries.
The cancer Genomic Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA).[1] PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member.[2]
[1] Food and Drug Administration Philippines. Checked 14 Nov 2026.
[2] PhilHealth. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how cancer Genomic Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Philippines.
What doctors and scientists are doing in Cancer Genomic Testing right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
Philippines · 2 shared keywords
Philippines · 1 shared keyword
Philippines · 1 shared keyword
Philippines
Philippines
Philippines
Pharmaceuticals · Philippines
Digital Health · Philippines
Healthcare Services · Philippines
Pharmaceuticals · Philippines
Pharmaceuticals · Philippines
Healthcare Services · Philippines